GoodRx Holdings (GDRX) Net Margin (2019 - 2026)

GoodRx Holdings has disclosed Net Margin across 8 years of filings, most recently posting 0.6% for Q1 2026.

• Net Margin for Q1 2026 came in at 0.6%, down 484.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2.61% (down 96.0% YoY), and the FY2025 annual result was 3.82%, up 175.0% from the prior year.
• Net Margin came in at 0.6% for Q1 2026 at GoodRx Holdings, down from 2.79% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 30.99% in Q2 2023 to a low of 22.28% in Q3 2022.
• The 5-year median for Net Margin is 0.6% (2026), against an average of 0.04%.
• Across the five-year window, Net Margin jumped 3173 bps in 2023 and slumped 2766 bps in 2024, its largest moves.
• GoodRx Holdings' Net Margin stood at 1.07% in 2022, then slumped by 1128 bps to 13.16% in 2023, then soared by 126 bps to 3.39% in 2024, then declined by 18 bps to 2.79% in 2025, then slumped by 78 bps to 0.6% in 2026.
• The last three Net Margin figures came in at 0.6% (Q1 2026), 2.79% (Q4 2025), and 0.57% (Q3 2025), per Business Quant data.